| OVERALL PORTFOLIO COMPOSITION (%) | |
| TOP 10 HOLDINGS ( 41.48% OF TOTAL ASSETS) | |
| Company | Symbol | % Assets | | Acorda Therapeutics, Inc. | ACOR | 4.02 | | Alexion Pharmaceuticals, Inc. | ALXN | 4.23 | | Amgen Inc. | AMGN | 3.98 | | Celgene Corporation | CELG | 4.26 | | Cephalon, Inc. | CEPH | 4.03 | | Dendreon Corporation | DNDN | 4.6 | | Gilead Sciences, Inc. | GILD | 4.01 | | Human Genome Sciences, Inc. | HGSI | 4.22 | | OSI Pharmaceuticals Inc. | OSIP | 4.07 | | Vertex Pharmaceuticals Incorpor | VRTX | 4.06 |
|
| Ratio | XBI | | Average Price/Earnings | 17.03 | | Average Price/Book | 2.33 | | Average Price/Sales | 2.87 | | Average Price/Cashflow | 5.38 |
|
| Sector | | XBI | | Software | | 0 | | Industrial Materials | | 0 | | Energy | | 0 | | Utilities | | 0 | | Hardware | | 0 | | Media | | 0 | | Telecommunication | | 0 | | Healthcare | | 99.98 | | Consumer Services | | 0 | | Business Services | | 0 | | Financial Services | | 0 | | Consumer Goods | | 0 |
|
| |
|
0.83% Nasdaq 
Holdings
